Tag: Novo nordisk

With over 40% of American adults classified as obese, medications like Ozempic have seen a surge in demand [1.2.7]. A common question is, **Does Eli Lilly make Ozempic?** The answer is no; Ozempic is manufactured by the Danish pharmaceutical company Novo Nordisk [1.4.2].

With a list price of around $1,350 for a 28-day supply, the monthly cost of Wegovy can be a significant financial burden for many. Understanding the factors that influence the price, from insurance coverage to manufacturer assistance programs, is crucial for anyone considering this popular weight loss medication.

According to a 2024 U.S. Senate committee report, a month's supply of Ozempic can cost as little as $59 in Germany, a stark contrast to the significantly higher prices in the United States. This major price difference raises questions about **how much is Ozempic in Germany**, the factors influencing the cost, and the role of the country's healthcare system.

According to the CDC, over 38 million Americans have diabetes, a chronic condition Ozempic is prescribed to treat. The generic name for Ozempic is **semaglutide**, an active ingredient also found in other popular medications, including Wegovy and Rybelsus.

Over 12% of US adults have used a GLP-1 drug, such as semaglutide, highlighting its widespread use. The complex process of how is semaglutide manufactured involves a multi-step journey, combining advanced biotechnology with precise chemical modifications to create a stable and effective therapeutic peptide.

In the United States, patents are expected to protect semaglutide until at least 2031, delaying any true generic availability. This timeline has fueled public discussion around the high costs and the question, **will there be a generic semaglutide**?

After a surge in demand that saw prescription fills for semaglutide increase by 442% between January 2021 and December 2023, many patients are asking: How long until Ozempic is back in stock? [1.2.1] As of February 2025, the FDA has officially declared the shortage resolved [1.2.2].

As of late 2025, there is no FDA-approved generic version of Wegovy (semaglutide) available in the United States, with patents potentially protecting the brand until the 2030s. This makes navigating the high cost of the brand-name drug a challenge for many, forcing them to explore alternatives or cost-saving strategies.

With the list price for a month's supply of Wegovy often exceeding $1,300, many wonder about the affordability of this popular weight-loss medication. The manufacturer's savings program once offered a path to a $25 copay for some patients, but the question remains: Can you really get Wegovy for $25 a month in today's market?.

As of recent manufacturer updates, the out-of-pocket cash price for uninsured patients using official programs is identical for Wegovy and Ozempic. This critical detail challenges the initial perception based on higher retail list prices for Wegovy and is vital for anyone considering which is cheaper without insurance, Wegovy or Ozempic, based purely on cost.